CMI
64
5
PSA
56
5
EMC
53
5
FITB
60
2
VTR
54
5
AAL
53
-4
MU
36
5
ILMN
37
5
EOG
56
-2
JNJ
44
3
PBI
65
5
ESS
64
4
XEL
69
2
UNP
45
6
GS
73
7
BF.B
31
3
JPM
67
4
WEC
55
2
NUE
58
7
DE
56
10
CMI
64
5
PSA
56
5
EMC
53
5
FITB
60
2
VTR
54
5
AAL
53
-4
MU
36
5
ILMN
37
5
EOG
56
-2
JNJ
44
3
PBI
65
5
ESS
64
4
XEL
69
2
UNP
45
6
GS
73
7
BF.B
31
3
JPM
67
4
WEC
55
2
NUE
58
7
DE
56
10
Financhill
Back

AirNet Technology 10K Form

Sell
39

ANTE
AirNet Technology

Last Price:
0.49
Seasonality Move:
12.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ANTE News And Ratings

See the #1 stock for the next 7 days that we like better than ANTE

ANTE Financial Statistics

Sales & Book Value

Annual Sales: $845K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $3.09
Price / Book: 0.16

Profitability

EPS (TTM): 3.22890
Net Income (TTM): $23.25M
Gross Margin: $-531K
Return on Equity: 0%
Return on Assets: 29.16%

AirNet Technology Earnings Forecast

Key AirNet Technology Financial Ratios

  • The Gross Profit Margin over the past 19 years for ANTE is -62.84%.
  • The Selling, General & Administrative Expenses for ANTE have been equal to 389.35% of Gross Profit Margin.
  • The Research & Development expenses have been 4.14% of Revenue.
  • The Interest Expense is -55.75% of Operating Income.
  • The Net Earning history of ANTE is -67.93% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 10 years.

AirNet Technology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Media
Sector: Communication Services
Current Symbol: ANTE
CUSIP: 00941Q
Website: ir.airnetgroup.cn

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.67
Quick Ratio: 0.35

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANTE Technical Analysis vs Fundamental Analysis

Sell
39
AirNet Technology (ANTE) is a Sell

Is AirNet Technology a Buy or a Sell?

  • AirNet Technology stock is rated a Sell
    The current AirNet Technology [ANTE] share price is $0.49. The Score for ANTE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.